PI3K/AKT/mTOR inhibitors for the management of triple-negative breast cancer
Crossref DOI link: https://doi.org/10.1007/s12032-024-02515-1
Published Online: 2024-10-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altundag, Kadri
Text and Data Mining valid from 2024-10-14
Version of Record valid from 2024-10-14
Article History
Received: 29 August 2024
Accepted: 19 September 2024
First Online: 14 October 2024
Declarations
:
: The authors declare no competing interests.
Free to read: This content has been made available to all.